Pillar Biosciences Launches oncoReveal® Myeloid v2 Panel, Expanding to 80 Genes and Advancing Detection of Long and Multiple FLT3-ITDs
NATICK, Mass., October 5, 2026 — Pillar Biosciences today announced the launch of the oncoReveal® Myeloid v2 Panel, an expanded research-use-only (RUO) DNA next-generation sequencing (NGS) panel for myeloid malignancies. The panel expands the original oncoReveal Myeloid Panel from 58 to 80 gene targets and enhances detection of FLT3 internal tandem duplications (ITDs), including long […]